|
| 明德生物(002932)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2023-10-09 | 194.04 | 0.83% | 15636.49 | 7615.61 | 15636.49 | 67.25% | 股权激励限售股份 | | 2023-08-21 | 12.28 | 0.05% | 15442.45 | 7809.65 | 15442.45 | 66.41% | 股权激励限售股份 | | 2022-10-10 | 142.68 | 0.91% | 10347.06 | 5272.24 | 10347.06 | 66.25% | 股权激励限售股份 | | 2022-08-19 | 9.66 | 0.06% | 10204.38 | 5414.92 | 10204.38 | 65.33% | 股权激励限售股份 | | 2022-05-18 | 825.98 | 7.88% | 6842.10 | 3645.70 | 6842.10 | 65.24% | 定向增发机构配售股份 | | 2021-10-11 | 130.37 | 1.35% | 9452.29 | 209.52 | 9661.81 | 100.00% | 股权激励限售流通 | | 2021-07-12 | 3656.30 | 52.99% | 6658.51 | 242.00 | 6900.51 | 100.00% | 发行前股份限售流通 | | 2019-07-10 | 1337.59 | 20.09% | 3002.22 | 3656.30 | 6658.51 | 100.00% | 发行前股份限售流通 |
|